Stuart McLachlan
Corporate Officer/Principal en Lypanosys Pte Ltd. .
Cargos activos de Stuart McLachlan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Lypanosys Pte Ltd.
 Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Corporate Officer/Principal | 06/06/2011 | - |
Historial de carrera de Stuart McLachlan
Formación de Stuart McLachlan.
| University of California, Davis | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 2 |
| Singapur | 2 |
Operativa
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Consumer Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
- Bolsa de valores
- Insiders
- Stuart McLachlan
- Experiencia
